Turtlemint Fintech IPO has received a lot of attention in India’s capital markets as it raised ₹882.67 crore. The IPO closed on June 23, 2026, when the share was subscribed 1.20 times overall, reflecting moderate investor interest. The company will go on an auction June 24 and refund and share credits to Demat accounts will happen by June 25. Investors are waiting for the date of June 29 when the stock will go public for the first time on the BSE and NSE.

Data on subscription show that institutional investors provided the best support, with Qualified Institutional Buyers subscribing 1.59 times. Retail investors followed with 1.07 times subscription and Non-Institutional Investors were behind at 0.52 times. This shows that institutional investors are confident but individual investors are being cautious given the company's financial performance.
There is a mild grey market premium on the market, around ₹152 (GMP) per share. Some of the trackers have reported a GMP of ₹1-2, indicating that no significant listing gains have been achieved. That is a sign that investors are not expecting a big climb on the day of listing, and the stock will likely go flat in the IPO. GMP trends are often a fairly informal gauge of market mood and in the present case they are probably optimistic at best.
Turtlemint Fintech is a phygital insurance distribution company in which digital tools are built in-house and offline agent networks are also used. The company partners with 44 insurers and has 6 lakh digital partners in India. In India it has a presence in almost 98% of the postal network, making it one of the most readily available insurance marketplaces. Despite the huge growth in revenue, the company did report a net loss of ₹194 crore for FY25, which remains a concern for investors.
For those who applied, the IPO allotment status is straightforward. Investors can check the BSE IPO page, the KFin Technologies portal, or the NSE IPO section. By entering their PAN, application number and Demat details, they can verify if shares have been allotted.
I think of the listing on June 29 as a key test of investor sentiment. GMP indicates limited short-term gains, but institutional support is in place and indicates confidence in Turtlemint as a long-term growth story. How the company can reduce losses and leverage its vast network will help the company deliver value to shareholders in the long term.